Wearable defibrillator use in heart failure (WIF): Results of a prospective registry

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Kao, Andrew C ^a   Krause, Steven W ^b   Handa, Rajiv ^c   Karia, Darshak ^d   Reyes, Guillermo ^e   Bianco, Nicole R ^f   Szymkiewicz, Steven J ^f  

^a ST LUKE S HOSPITAL   (United States)

^b Blessing Hospital   (United States)

^c Metro Heart Group of St Louis   (United States)

^d ALBERT EINSTEIN MEDICAL CENTER   (United States)

^e Cardiology of San Antonio   (United States)

^f ZOLL Medical Corporation   (United States)

Author keywords

Heart failure; Sudden cardiac death; Wearable cardioverter defibrillator

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT;

ADULT; AGE; AGED; ARTICLE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATION; DEFIBRILLATOR; DISEASE REGISTRY; EARLY INTERVENTION; FEMALE; HEART ARREST; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; MORTALITY; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; SUDDEN DEATH; TREATMENT OUTCOME;

ADULT; AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84870862600     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-123     Document Type: Article

References (24)

1. Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G. Mechanism of death in heart failure. The vasodilator-heart failure trials. The V-HeFT VA cooperative studies group. Circulation 1993, 87:VI24-31.
2. Nagele H, Rodiger W. Sudden death and tailored medical therapy in elective candidates for heart transplantation. J Heart Lung Transplant 1999, 18:869-876. 10.1016/S1053-2498(99)00040-6, 10528749.
3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
4. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397-1402. 10.1056/NEJMoa020265, 12409541.
5. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 1985, 72:681-685. 10.1161/01.CIR.72.4.681, 2863012.
6. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883. 10.1056/NEJMoa013474, 11907286.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237. 10.1056/NEJMoa043399, 15659722.
8. Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 2009, 120:2170-2176. 10.1161/CIRCULATIONAHA.109.853689, 2922511, 19917887.
9. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004, 350:2151-2158. 10.1056/NEJMoa033088, 15152060.
10. Saba S, Atiga WL, Barrington W, Ganz LI, Kormos RL, MacGowan GA, Mathier MA, McNamara DM, Obioha-Ngwu O, Murali S. Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication. J Heart Lung Transplant 2003, 22:411-418. 10.1016/S1053-2498(02)00573-9, 12681418.
11. Sandner SE, Wieselthaler G, Zuckermann A, Taghavi S, Schmidinger H, Pacher R, Ploner M, Laufer G, Wolner E, Grimm M. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 2001, 104:I171-176.
12. Ermis C, Zadeii G, Zhu AX, Fabian W, Collins J, Lurie KG, Sakaguchi S, Benditt DG. Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment. J Cardiovasc Electrophysiol 2003, 14:578-583. 10.1046/j.1540-8167.2003.02590.x, 12875416.
13. Chen L, Hay JW. Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure. Cardiovasc Drugs Ther 2004, 18:161-170.
14. Stevenson LW, Desai AS. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. J Card Fail 2006, 12:407-412. 10.1016/j.cardfail.2006.06.001, 16911905.
15. Centers for Medicare & Medicaid Services Coverage determinations: implantable automatic defibrillators. Medicare National Coverage Determinations Manual 2010, Baltimore, Md. CMS-Pub, 100-3; Pt 1, section 20.4. Available at: http://cms.hhs.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=110&ncdver=3&bc=AgAAQAAAAAAA&. Accessed December 23, Centers for Medicare & Medicaid Services.
16. Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, Boehmer J, Harvey M, Heilman MS, Szymkiewicz SJ, Moss AJ. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 2004, 27:4-9. 10.1111/j.1540-8159.2004.00378.x, 14720148.
17. Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, Jons C, Szymkiewicz S, Buhtz F, Wollbrueck A, et al. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol 2010, 33:353-367. 10.1111/j.1540-8159.2009.02590.x, 19889186.
18. Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD, Tchou PJ. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol 2010, 56:194-203. 10.1016/j.jacc.2010.04.016, 2962668, 20620738.
19. Brown SB, Shannon RP. Improving medication compliance in patients with heart failure. Am J Cardiol 2008, 101:274-277. 10.1016/j.amjcard.2007.07.073, 18178422.
20. Binkley PF, Lesinski A, Ferguson JP, Hatton PS, Yamokoski L, Hardikar S, Cooke GE, Leier CV. Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event. Am Heart J 2008, 155:69-74. 10.1016/j.ahj.2007.08.010, 18082492.
21. Moon J, Ko YG, Chung N, Ha JW, Kang SM, Choi EY, Rim SJ. Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy. Can J Cardiol 2009, 25:e147-150. 10.1016/S0828-282X(09)70497-0, 2707172, 19417864.
22. McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001, 103:2254-2259. 10.1161/01.CIR.103.18.2254, 11342473.
23. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:1977-2016.
24. Bueno H, Ross JS, Wang Y, Chen J, Vidan MT, Normand SL, Curtis JP, Drye EE, Lichtman JH, Keenan PS, et al. Trends in length of stay and short-term outcomes among medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010, 303:2141-2147. 10.1001/jama.2010.748, 3020983, 20516414.